Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Advanced Drug Delivery Reviews|November 18, 2005
Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complexAnil K Patri, Jolanta F Kukowska-Latallo, James R BakerVaccine|March 31, 2015
Nanoemulsion-based mucosal adjuvant induces apoptosis in human epithelial cellsBeata U Orzechowska, Jolanta F Kukowska-Latallo, Alexa D Coulter, et al.The Journal of Allergy and Clinical Immunology|December 6, 2003
Nasal mucosal gene expression in patients with allergic rhinitis with and without nasal polypsStephen B Fritz, Jeffrey E Terrell, Edward R Conner, et al.Journal of Medicinal Chemistry|May 27, 2005
Targeting and inhibition of cell growth by an engineered dendritic nanodeviceThommey P Thomas, Istvan J Majoros, Alina Kotlyar, et al.Molecular Pharmaceutics|March 6, 2013
Polyplex exposure inhibits cell cycle, increases inflammatory response, and can cause protein expression without cell divisionRebecca L Matz, Blake Erickson, Sriram Vaidyanathan, et al.Vaccine|January 1, 2013
Nanoemulsion nasal adjuvant W₈₀5EC induces dendritic cell engulfment of antigen-primed epithelial cellsAndrzej Myc, Jolanta F Kukowska-Latallo, Douglas M Smith, et al.Bioorganic & Medicinal Chemistry Letters|April 7, 2012
The facile synthesis of multifunctional PAMAM dendrimer conjugates through copper-free click chemistryBaohua Huang, Jolanta F Kukowska-Latallo, Shengzhuang Tang, et al.International Journal of Nanomedicine|August 9, 2008
Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancementScott D Swanson, Jolanta F Kukowska-Latallo, Anil K Patri, et al.Bioconjugate Chemistry|August 17, 2010
RGD dendron bodies; synthetic avidity agents with defined and potentially interchangeable effector sites that can substitute for antibodiesDaniel Q McNerny, Jolanta F Kukowska-Latallo, Douglas G Mullen, et al.Cancer Research|June 17, 2005
Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancerJolanta F Kukowska-Latallo, Kimberly A Candido, Zhengyi Cao, et al.Pageof 2